The Diversity Jurisdiction Inflation Adjustment Act updates the minimum monetary threshold required for federal courts to hear cases based on diversity of citizenship. It raises the current limit of $75,000 to $150,000 and establishes a mechanism to automatically adjust this amount every ten years starting in 2030 based on changes in the Consumer Price Index. The Director of the Administrative Office of the United States Courts will calculate these adjustments and publish them annually, ensuring the threshold keeps pace with inflation. Additionally, the bill clarifies that if a plaintiff recovers less than the required amount, the court may deny or impose costs on them. This legislation directly affects individuals and businesses seeking to file civil lawsuits in federal court by changing the financial requirements for jurisdiction.
This bill extends the funding authorization for the Accelerating Access to Critical Therapies for ALS Act from 2026 to 2031, ensuring continued financial support for research into treatments for amyotrophic lateral sclerosis. It requires the Food and Drug Administration to review clinical trial data more rigorously by assessing patient enrollment numbers and requesting interim results from drug manufacturers before renewing research grants. Additionally, the legislation clarifies that clinical trials in phase 3 include combined phase 2/3 studies and planned trials that have not yet started enrolling participants. The bill also mandates the FDA to publish a report within a year of enactment detailing its progress on rare neurodegenerative disease action plans and how it coordinates with broader disease communities. Finally, it adjusts the timeline for a Government Accountability Office report to cover a five-year period instead of four.
This bill raises the debt thresholds for qualifying for certain bankruptcy protections under U.S. law. It increases the small business bankruptcy limit (Chapter 11) from $750,000 to $7.5 million in total debts, allowing more small business owners to file. For consumer bankruptcy (Chapter 13), it raises the individual debt limit from $1 million to $2.75 million (or $2.75 million for a couple), excluding stockbrokers and commodity brokers. The changes apply to cases filed after the bill's enactment, directly affecting small business owners and consumers with higher debt levels who previously couldn't qualify.
This bill amends the Public Safety Officers' Benefit Program to improve processing of claims for officers injured or killed in the line of duty. It establishes clear timelines for the Bureau to notify claimants about missing information (90 days) and make determinations (270 days), with automatic interim benefits issued if deadlines aren't met. The bill requires regular outreach to public safety officers and underserved agencies, mandates annual audits of backlogged claims, and strengthens subpoena authority to obtain necessary information. It also creates a pathway for expedited processing when claims are approved by the 9/11 Victim Compensation Fund or World Trade Center Health Program. The bill does not change benefit amounts but aims to make the claims process more efficient and transparent for public safety officers and their families.
This bill establishes the "INCLUDE Project" at the National Institutes of Health (NIH) to advance research on Down syndrome. It directs NIH to coordinate and expand research into co-occurring health conditions (like Alzheimer's, heart disease, and autoimmune disorders) affecting individuals with Down syndrome, while avoiding duplication of existing efforts. The law requires NIH to build large study populations, support inclusive clinical trials, identify biomarkers, and improve quality of life for people with Down syndrome and their families. NIH must submit biennial reports to Congress detailing research progress and findings. The bill directly affects NIH research programs and future medical care for people with Down syndrome.
National Plan for Epilepsy Act This bill requires the Department of Health and Human Services (HHS) to establish a national plan, form an advisory council, and take other actions to address epilepsy. The requirements sunset on December 31, 2035. Specifically, the bill requires HHS to carry out a National Plan for Epilepsy to prevent, diagnose, treat, and cure epilepsy. In carrying out the plan, HHS must implement activities such as coordinating research and services across all federal agencies and soliciting public comments. Also, HHS must establish an Advisory Council on Epilepsy Research, Care, and Services. The advisory council must report to HHS and Congress every two years with an evaluation of federally funded efforts. Additionally, HHS must annually report to Congress with recommended actions based on its assessments of the nation’s progress on epilepsy.
This resolution designates the week of August 22 through August 30, 2026, as "National Park Week." It directly affects the public by encouraging responsible visits and support for the National Park System, which includes parks, battlefields, and historical sites located across the United States and its territories. The measure serves as a formal declaration to highlight the parks' role in recreation, education, and economic activity without altering any laws or funding.
This resolution designates August 1, 2026, as Gold Star Children's Day to honor the sacrifices and hardships faced by children of fallen members of the U.S. Armed Forces. The bill does not create new laws or change government operations; instead, it serves as a formal expression of gratitude from the Senate and encourages the public to observe this day in support of these families. By establishing this specific date, the measure aims to raise awareness about the legacy carried by children who lost a parent in military service.
This Senate resolution designates July 2026 as National Anti-Counterfeiting and Consumer Education and Awareness Month to highlight the economic and safety importance of trademarks. The bill aims to educate the public about the risks of counterfeit goods, such as unsafe medical products and electronics, and encourages awareness campaigns to reduce demand for these illegal items. By promoting education on how to identify genuine products, the resolution seeks to help consumers avoid harmful fakes while supporting brand owners and law enforcement efforts.
This bill reauthorizes and expands the Accelerating Access to Critical Therapies for ALS Act through 2031, extending funding for research into treatments for amyotrophic lateral sclerosis. It requires drug manufacturers to share interim clinical trial data with the FDA to better assess the progress of investigational drugs and clarifies that phase 3 clinical trial definitions include combined phase 2/3 trials and planned trials not yet enrolling participants. The legislation also mandates the FDA to publish an updated five-year action plan for ALS and other rare neurodegenerative diseases, including resource needs and coordination strategies with broader disease communities. Additionally, the bill requires the Government Accountability Office to submit a report on the program's implementation four years after enactment.
This bill reauthorizes federal programs focused on preventing and responding to tick-borne diseases through 2026-2030, extending existing efforts beyond their previous expiration. It updates the National Strategy for Vector-Borne Diseases to emphasize identifying, reporting, preventing, and responding to these illnesses. The bill modifies two sections of the Public Health Service Act to continue funding for health departments working on vector-borne disease control. It directly affects public health programs and state/local health departments managing tick-borne disease prevention and response.
The AADAPT Act reauthorizes and expands Project ECHO grants to improve Alzheimer’s and dementia care through technology-enabled training. It specifically funds grants for healthcare providers in rural, frontier, or medically underserved areas to enhance early diagnosis, quality care, and provider retention for dementia patients. The bill authorizes $1 million annually (2027-2032) for these dementia-focused training programs, requiring funds to supplement - not replace - existing resources. This directly supports primary care providers licensed to serve underserved communities, using collaborative online learning to address care gaps.
